?

Which patients are most likely to benefit?

active
open question Created: 2026-04-25T20:28:26 By: backfill_open_questions Quality: 50% ✓ SciDEX ID: open_question-9e3fd320-94eb-4016-99eb-79
Open Question open Wiki: therapeutics-vagus-nerve-stimulation-parkinsons-disease
Which patients are most likely to benefit?
Importance Elo
1500
Field Rank
Rank #975 in therapeutics
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page therapeutics-vagus-nerve-stimulation-parkinsons-disease
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
No cross-references found yet. Evidence matching runs daily.
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
No derived artifacts linked yet.
Related Entities
therapeutics
Metadata
statusopen
_origin{'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:28:26.769961'}
field_tagtherapeutics
source_idtherapeutics-vagus-nerve-stimulation-parkinsons-disease
sub_fieldvagus-nerve-stimulation-parkinsons-disease
source_kindwiki
question_hash741ad15f9d0ce64bcf9b50a26e7afcc1a7df1adfdef3662bef8cb3f415fd2851
question_textWhich patients are most likely to benefit?
importance_elo1500
_schema_version1
evidence_summaryExtracted from wiki page therapeutics-vagus-nerve-stimulation-parkinsons-disease
tractability_score0.5
potential_impact_score0.5
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
1
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.